Hospitalization costs in schizophrenia (SC) and projection of costs with the adoption of a long-term release formulation of paliperidone palmitate (LRPP)- real world data analysis
Abstract
Authors
J.M. Meneses O.A.C. Clark A.M. Nishikawa